Abstract
Evidence from epidemiological, clinical, and laboratory studies including animal experiments suggests that cancer develops from a complex, multistage interaction between genetic and environmental factors. In colorectal cancer, the environmental component of the process, which is diet, contributes more to cancer formation than the inheritance factor in most people (Doll 1980). The diet contains a large number of compounds that affect the carcinogenic process in some manner, and it is their combined effect that determines the degree of cancer risk from dietary factors. Since the identification and elimination of the carcinogens that initiate colon cancer formation appear to be difficult, the current emphasis in research on prevention is focused mainly on ways to alter the carcinogenic process. While a complete interruption of the process is desirable, it is not essential because simply slowing its progression enough so that clinical cancer does not develop during the normal span of life would also prevent cancer morbidity and mortality.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abeloff MD, Slavik M, Luk GD, Griffin CA, Hermann J, Blanc O, Sjoersdma A, Baylin SB (1984) Phase I trial and pharmacokinetic studies of alpha-difluoromethylomithine — an inhibitor of polyamine biosynthesis. J Clin Oncol 2: 124–130
Abeloff MD, Rosen ST, Luk GD, Baylin SB, Zeltzman M, Sjoersdma A (1986) Phase II trials of alpha-difluoromethylornithine, an inhibitor of polyamine synthesis, on advanced small cell lung cancer and colon cancer. Cancer Treat Rep 70: 843–845
Barbolt TA, Abraham R (1977) Experientia 35: 257–258
Bertram JS, Kolonel LN, Meyskens FL (1987) Rational and strategies for chemoprevention of cancer in humans. Cancer Res 47: 3012–3031
Buell DN (1983) Potential hazards of selenium as a chemopreventive agent. Semin Oncol 10: 311–321
Bull AW, Burd AD, Nigro ND (1981) Effect of inhibitors of tumorigenesis on the formation of 06-methylguanine in the colon of 1,2-dimethylhydrazine-treated rats. Cancer Res 41: 4938–4941
Bull AW, Bird RP, Bruce RW, Nigro ND, Medine A (1987) Effect of calcium on azoxymethaneinduced intestinal tumors in rats. Gastroenterology 92: 1332
Clark LC (1985) The epidemiology of selenium and cancer. Fed Proc 44: 2584–2589
Clark LC, Combs GF (1986) Selenium compounds and the prevention of cancer: research needs and public health implications. J Nutr 116: 170–173
Cook MG, McNamara P (1980) Effect of dietary vitamin E on dimethylhydrazine-induced colonic tumors in mice. Cancer Res 40: 1329–1331
Deschner EE, Cohen BI, Raicht RF (1982) The kinetics of the protective effect of beta-sitosterol against MNU-induced colonic neoplasia. J Cancer Res Clin Oncol 103: 49–54
Doll R (1980) The epidemiology of cancer. Cancer 45: 2475–2485
Fiala ES, Bobotas G, Kulakis C, Wattenberg LW, Weisberger JH (1977) Effects of disulfiram and related compounds on the metabolism in vivo of the colon carcinogen, 1,2-dimethylhydrazine. Biochem Pharmacol 26: 1763–1968
Honn KV, Bockman RS, Marnett LJ (1981) Prostaglandins and cancer: a review of tumor initiation through tumor metastases. Prostaglandins 21: 833–864
Jacobs M, Forst C (19819 Toxicological effects of sodium selenite in Swiss mice. J Toxicol Environ Health 8: 587–598
Jacobs MM, Jansson B, Griffin AC (1977) Inhibitory effects of selenium on 1,2-dimethylhydrazine and methylazoxymethanol acetate induction of colon tumors. Cancer Lett 2: 133–138
Kingsnorth AN, King WWK, Diekma KA, McCann PP, Ross JS, Malt RA (1983) Inhibition of ornithine decarboxylase with 2-difluoromethyl-ornithine: reduced incidence of dimethylhydrazine-induced colon tumors in mice. Cancer Res 43: 2545–2549
Kudo T, Narisawa T, Abo S (1980) Antitumor activity of indomethacin on methylazoxymethanolinduced large bowel tumors in rats. Gann 71: 260–264
Lane HW, Medina D (1983). Selenium concentration and glutathione peroxidase activity in normal and neoplastic development of the mouse mammary gland. Cancer Res 43: 1558–1561
LeBouef RA, Hoekstra WG (1985) Changes in cellular glutathione levels: possible relation to selenium-mediated anticarcinogenesis. Fed Proc 44: 2563–2567
Levander OA, Morris VC (1984) Dietary selenium levels needed to maintain balance in North American adults consuming self-selected diets. Am J Clin Nutr 39: 809–815
Lipkin M, Newmark HL (1985) Effect of added dietary calcium on colonic epithelial cell proliferation in subjects at high risk for familial colonic cancer. N Engl J Med 313: 1381–1384
Luk GD, Hamilton SR, Yang P, Smith JA, O’Ceallaigh DO, McAvinchey D, Hyland J (1986) Kinetic changes in mucosal ornithine decarboxylase activity during azoxymethane-induced colonic carcinogenesis in the rat. Cancer Res 46: 4449–4452
Narisawa T, Kono K, Yamaguchi T, Takahashi T (1978) Cancer chemotherapy using autochthonous large bowel cancer in rats. Gann 69: 431–435
Narisawa T, Sato M, Tani M, Kudo T, Takahashi T, Goto A (1981) Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment. Cancer Res 41: 1954–1957
National Research Council (1980) Recommended dietary allowances, 9th edn. National Academy Press, Washington DC
Newmark HL, Wargovich MJ, Bruce WR (1984) Colon cancer and dietary fat, phosphate, and calcium: a hypothesis. JNCI 72: 1323–1325
Nigro ND, Campbell RL (1978) Inhibition of azoxymethane-induced intestinal cancer by disulfiram. Cancer Lett 5: 91–95
Nigro ND, Bull AW, Wilson PS, Soullier BK, Alousi MA (1982) Combined inhibitors of carcinogenesis: effect on azoxymethane-induced intestinal cancer in rats. JNCI 69: 103–107
Nigro ND, Bull AW, Boyd ME (1986) Inhibition of intestinal carcinogenesis in rats: effect of difluoromethylornithine with piroxicam or fish oil. JNCI 77: 1309–1313
Pence B, Buddingh F (1987) Inhibition of dietary fat promotion of colon carcinogenesis by supplemental calcium or vitamin D. Proc Am Assoc Cancer Res 28: 154
Pollard M, Luckert PH (1983) Prolonged antitumor effect of indomethacin on autochthonous intestinal tumors in rats. JNCI 70: 1103–1105
Pollard M, Luckert PH, Schmidt MA (1983) The suppressive effect of piroxicam on autochthonous intestinal tumors in the rat. Cancer Lett 21: 57–61
Raicht RF, Cohen BI, Fazzini EP, Sarwal AN, Takahashi M (1980) Protective effect of plant sterols against chemically induced colon tumors. Cancer Res 40: 403–405
Reddy BS, Maeura Y, Weisburger JH (1983) Effect of various levels of dietary butylated hydroxyanisole on methylazoxymethanol acetate-induced colon carcinogenesis in CFI mice. JNCI 71: 1299–1305
Rozhin J, Wilson PS, Bull AW, Nigro ND (1984) Ornithine decarboxylase activity in the rat and human colon. Cancer Res 44: 3226–3230
Shamberger RJ, Willis CE (1971) Selenium distribution and human cancer mortality. CRC Crit Rev Clin Lab Sci 2: 211–221
Soullier BK, Wilson PS, Nigro ND (1981) Effect of selenium on azoxymethane-induced intestinal cancer in rats fed high fat diet. Cancer Lett 12: 343–348
Subbish R (1971) Significance of dietary plant sterols in man and experimental animals. Mayo Clin Proc 46: 549–559
Sunkara PS, Rosenberger AL (1987) Antimetastastic activity of DL-alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, in mice. Cancer Res 47: 933–935
Tutton PJM, Barkla DH (1986) Comparison of the effects of an ornithine decarboxylaxe inhibitor on the intestinal epithelium and on intestinal tumors. Cancer Res 46: 6091–6094
Waddell WR, Loughry RW (1983) Sulindac for polyposis of the colon. J Surg Oncol 24: 83–87
Wargovich MJ (1987) Diallyl sulfide, a flavor component of garlic (Allium sativum), inhibits dimethylhydrazine-induced colon cancer. Carcinogenesis 8: 1239–1241
Wargovich MJ, Goldberg MT (1985) Diallyl sulfide: a naturally occurring thioether that inhibits carcinogen-induced nuclear damage to colon epithelial cells in vivo. Mutat Res 143: 127–129
Wattenberg LW (1975) Inhibition of dimethylhydrazine-induced neoplasia of the large intestine by disulfiram. JNCI 54: 1005–1006
Wattenberg LW (1983) Inhibition of neoplasia by minor dietary constituents. Cancer Res (Suppl) 43: 2448s - 2453s
Wattenberg LW (1984) Inhibition of carcinogen-induced neoplasia by sodium cyanate, tert-butyl isocyanate, and benzyl isothiocyanate administered subsequent to carcinogen exposure. Cancer Res 41: 2991–2994
Wattenberg LW (1985) Chemoprevention of cancer. Cancer Res 45: 1–8
Weed HG, McGandy RB, Kennedy AR (1985) Protection against dimethylhydrazine-induced adenomatous tumors of the mouse colon by the dietary addition of an extract of soybeans containing the Bowman-Birk protease inhibitor. Carcinogenesis 8: 1239–1241
Weisburger EK, Evarts RP, Wenk ML (1977) Inhibitory effect of butylated hydroxytoluene ( BHT) on intestinal carcinogenesis in rats by azoxymethane. Food Cosmet Toxicol 15: 139–141
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Nigro, N.D., Bull, A.W. (1989). Inhibitors of Colorectal Carcinogenesis: Experimental and Therapeutic Aspects. In: Seitz, H.K., Simanowski, U.A., Wright, N.A. (eds) Colorectal Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85930-4_19
Download citation
DOI: https://doi.org/10.1007/978-3-642-85930-4_19
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-85932-8
Online ISBN: 978-3-642-85930-4
eBook Packages: Springer Book Archive